QC
LLY icon

QCM Cayman’s Eli Lilly LLY Stock Holding History

QCM Cayman’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-635
Closed -$298K – 91
2023
Q2 		$298K Sell
635
-698
-52% -$293K 1.75% 20
2023
Q1 		$458K Buy
+1,333
New +$450K 2.87% 7
2022
Q4 		– Sell
-674
Closed -$218K – 54
2022
Q3 		$218K Buy
+674
New +$214K 3.18% 16
2016
Q3 		– Sell
-2,637
Closed -$208K – 288
2016
Q2 		$208K Sell
2,637
-237
-8% -$17.8K 0.09% 222
2016
Q1 		$207K Buy
+2,874
New +$217K 0.14% 135

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

QCM Cayman's LLY Position: Q3 2023 in Review

QCM Cayman sold out of Eli Lilly (LLY) in Q3 2023, closing a stake of 635 shares — an estimated $298K sold.

QCM Cayman first reported a position in LLY in Q1 2016 and held it in 5 quarters. The position peaked at $458K in Q1 2023. 2,975 funds tracked by Wall St. Rank hold LLY as of Q3 2023.

  • QCM Cayman reported no remaining Eli Lilly position as of Q3 2023 after selling out during the quarter.
  • QCM Cayman sold 635 Eli Lilly shares in Q3 2023, an estimated $298K.
  • QCM Cayman first reported a position in Eli Lilly in Q1 2016 and held it in 5 quarters.
  • QCM Cayman's Eli Lilly position peaked at $458K in Q1 2023.
  • 2,975 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2023.

Based on QCM Cayman's 13F filing for Q3 2023, filed 30 Oct 2023.